Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Airbnb | Lin Alfred | Director | 23 Feb 2024 | 3,937,028 | 4,405,300 | - | 0 | Class A Common Stock | ||
| Airbnb | Lin Alfred | Director | 23 Feb 2024 | 3,937,028 | 19,216,870 | - | - | Class B Common Stock | ||
| Airbnb | Alfred Lin | Director | Other type of transaction at price $ 0.00 per share. | 23 Feb 2024 | 3,937,028 | 468,272 | - | 0 | Class A Common Stock | |
| Lloyds Banking Grp PLC (ADR) | Budenberg Robin | Non-Executive Director,Chairman | Purchase of securities on an exchange or from another person at price $ 0.45 per share. | 23 Feb 2024 | 1,000,000 | 2,500,000 (0%) | 0% | 0.5 | 454,925 | Ords |
| BRC Inc (Class A) | Chris Mondzelewski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 860,664 | 860,664 | - | - | Stock Option (right to buy) | |
| Airbnb | Alfred Lin | Director | Other type of transaction at price $ 0.00 per share. | 23 Feb 2024 | 855,488 | 46,744 | - | 0 | Class A Common Stock | |
| Airbnb | Alfred Lin | Director | 23 Feb 2024 | 855,467 | 902,232 | - | 0 | Class A Common Stock | ||
| Airbnb | Lin Alfred | Director | 23 Feb 2024 | 855,467 | 2,972,812 | - | - | Class B Common Stock | ||
| Sarcos Tech and Robotics Corp | G. Benjamin Wolff | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 625,000 | 1,233,787 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 505,000 | 505,000 | - | - | Stock Option (Right to buy) | |
| Sarcos Tech and Robotics Corp | Denis Garagic | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 500,000 | 555,116 | - | 0 | Common Stock | |
| Weave Comm Inc | Tyler Newton | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Feb 2024 | 500,000 | 8,983,136 | - | 0 | Common Stock, par value $0.0001 per share | |
| Fiserv | Frank J. Bisignano | Director, Chairman, President and CEO | 23 Feb 2024 | 447,339 | 3,403,074 (0%) | 0% | 52.8 | 23,623,973 | Common Stock | |
| Fiserv | Bisignano J. Frank | Director, Chairman, President and CEO | 23 Feb 2024 | 447,339 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Natera Inc | Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 380,036 | 0 | - | - | Stock Option (right to buy) | |
| Natera Inc | Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.66 per share. | 23 Feb 2024 | 380,036 | 1,050,036 (1%) | 0% | 2.7 | 1,009,718 | Common Stock |
| Cleanspark Inc | Zachary K. Bradford | Director, CEO and President | 23 Feb 2024 | 363,900 | 3,275,856 (67%) | 7% | 21 | 7,641,900 | Common Stock | |
| Starwood Property Trust Inc | S. Sternlicht Barry | Director, CEO, Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 330,787 | 2,342,126 (0%) | 0% | - | Common Stock | |
| Cleanspark Inc | Matthew S. Schultz | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 20.95 per share. | 23 Feb 2024 | 322,400 | 2,698,768 (55%) | 6% | 21.0 | 6,754,280 | Common Stock |
| American Well Corp (Class A) | Shepardson Robert | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 23 Feb 2024 | 319,214 | 2,845,148 | - | 1.1 | 348,486 | Class A Common Stock |
| Fiserv | J. Frank Bisignano | Director, Chairman, President and CEO | 23 Feb 2024 | 313,453 | 3,089,621 (0%) | 0% | 150.8 | 47,256,174 | Common Stock | |
| BRC Inc (Class A) | John Christopher Clark | CTO & COO | 23 Feb 2024 | 309,839 | 309,839 | - | - | Stock Option (right to buy) | ||
| Cleanspark Inc | Zachary Bradford K. | Director, CEO and President | 23 Feb 2024 | 300,000 | 3,575,856 (73%) | 6% | 0 | Common Stock | ||
| Cleanspark Inc | K. Zachary Bradford | Director, CEO and President | 23 Feb 2024 | 300,000 | 3,875,856 (79%) | 6% | 0 | Common Stock | ||
| Cleanspark Inc | Bradford K. Zachary | Director, CEO and President | 23 Feb 2024 | 300,000 | 0 | - | - | Restricted Stock Unit | ||
| Cleanspark Inc | K. Zachary Bradford | Director, CEO and President | 23 Feb 2024 | 300,000 | 300,000 | - | - | Restricted Stock Unit | ||
| American Well Corp (Class A) | Phyllis Gotlib | President, International | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 23 Feb 2024 | 285,752 | 2,488,798 | - | 1.1 | 311,955 | Class A Common Stock |
| American Well Corp (Class A) | Johnson Kathy Weiler | Chief Comm. & Growth Officer | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 23 Feb 2024 | 283,192 | 3,975,617 | - | 1.1 | 309,161 | Class A Common Stock |
| American Well Corp (Class A) | Knight Kurt | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 23 Feb 2024 | 283,079 | 3,114,004 | - | 1.1 | 309,037 | Class A Common Stock |
| Cleanspark Inc | Schultz S. Matthew | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 270,000 | 270,000 | - | - | Restricted Stock Unit | |
| Cleanspark Inc | Schultz Matthew S. | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 270,000 | 3,258,768 (66%) | 5% | 0 | Common Stock | |
| Cleanspark Inc | Matthew S. Schultz | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 270,000 | 2,988,768 (61%) | 5% | 0 | Common Stock | |
| Cleanspark Inc | S. Matthew Schultz | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 270,000 | 0 | - | - | Restricted Stock Unit | |
| Avantor Inc | Michael Stubblefield | Director, President & CEO | 23 Feb 2024 | 263,558 | 263,558 | - | - | Stock Options (Right to Buy) | ||
| ARKO Corp (Class A) | Kotler Arie | Director, Chairman, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 252,000 | 11,548,672 | - | 0 | Common Stock, par value $0.0001 per share | |
| American Well Corp (Class A) | Vukasin Paunovich | EVP, Enterprise Platforms | 23 Feb 2024 | 251,323 | 2,535,635 | - | 1.1 | 274,369 | Class A Common Stock | |
| Acurx Pharma Inc | David P. Luci | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 250,000 | 250,000 | - | - | Stock Option | |
| Acurx Pharma Inc | Robert J. Deluccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 250,000 | 250,000 | - | - | Stock Option | |
| Exelixis Inc | Morrissey Michael M. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 241,670 | 1,038,327 (0%) | 0% | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 215,000 | 215,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 205,000 | 205,000 | - | - | Stock Option (Right to buy) | |
| Cleanspark Inc | Zimmerman Andrew | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 200,000 | 538,035 (11%) | 4% | 0 | Common Stock | |
| Cleanspark Inc | Zimmerman Andrew | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 200,000 | 738,035 (15%) | 4% | 0 | Common Stock | |
| Cleanspark Inc | Zimmerman Andrew | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 200,000 | 0 | - | - | Restricted Stock Unit | |
| Cleanspark Inc | Zimmerman Andrew | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 200,000 | 200,000 | - | - | Restricted Stock Unit | |
| KAR Auction Services Inc | Hallett James P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.74 per share. | 23 Feb 2024 | 194,404 | 878,243 (0%) | 0% | 11.7 | 2,282,303 | Common Stock |
| KAR Auction Services Inc | P. James Hallett | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 194,404 | 0 | - | - | Employee Stock Option (right to buy) | |
| Arvinas Inc | John Houston G. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 184,200 | 184,200 | - | - | Stock Option (right to buy) | |
| Sarcos Tech and Robotics Corp | Benjamin G. Wolff | Director, PRESIDENT & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 170,974 | 0 | - | - | Stock Option (right to buy) | |
| Sarcos Tech and Robotics Corp | Laura Peterson J. | Director, EXECUTIVE VICE CHAIR | 23 Feb 2024 | 169,319 | 178,135 | - | 0 | Common Stock | ||
| KAR Auction Services Inc | Hallett James P. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.06 per share. | 23 Feb 2024 | 164,294 | 713,949 (0%) | 0% | 15.1 | 2,474,268 | Common Stock |
| BRC Inc (Class A) | Mondzelewski Chris | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 159,847 | 350,232 | - | 0 | Class A Common Stock | |
| Schneider National Inc (Class B) | Mark B. Rourke | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 148,107 | 410,797 (0%) | 0% | 0 | Class B Common Stock | |
| Acurx Pharma Inc | Robert G. Shawah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 145,000 | 145,000 | - | - | Stock Option | |
| Arch Capital | Marc Grandisson | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 138,190 | 258,674 (0%) | 0% | 0 | Common Shares, $.0011 par value per share | |
| BRC Inc (Class A) | Andrew McCormick | Gen. Counsel & Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 137,706 | 137,706 | - | - | Stock Option (right to buy) | |
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 136,276 | 0 | - | - | Employee Stock Option (right to buy) | |
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.07 per share. | 23 Feb 2024 | 136,276 | 277,497 (0%) | 0% | 56.1 | 7,640,995 | Class A Common Stock |
| Maplebear Inc | Ravi Gupta | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 29.93 per share. | 23 Feb 2024 | 135,072 | 2,147,931 | - | 29.9 | 4,043,286 | Common Stock |
| Alkermes PLC | C. Blair Jackson | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 134,771 | 134,771 | - | - | Employee Stock Option (Right to Buy) | |
| Hilltop Holdings Inc | Jeremy Ford B. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 131,713 | 1,533,510 (1%) | 0% | 0 | Common Stock | |
| Outset Medical Inc | L. Leslie Trigg | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 131,687 | 964,778 | - | 0 | Common Stock | |
| Pfizer | Bourla Albert | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 127,674 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Albert Bourla | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2024 | 127,674 | 439,748 (0%) | 0% | 27.3 | 3,490,607 | Common Stock |
| Fiserv | J. Bisignano Frank | Director, Chairman, President and CEO | 23 Feb 2024 | 126,427 | 3,216,048 (0%) | 0% | 41.3 | 5,225,228 | Common Stock | |
| Fiserv | Frank J. Bisignano | Director, Chairman, President and CEO | 23 Feb 2024 | 126,427 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Jasbir Seehra | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Cushman & Wakefield PLC | White Brett | Director, Executive Chairman | 23 Feb 2024 | 124,564 | 249,128 | - | - | Restricted Stock Units | ||
| Cushman & Wakefield PLC | Brett White | Director, Executive Chairman | 23 Feb 2024 | 124,564 | 1,503,455 (0%) | 0% | 0 | Ordinary Shares | ||
| Arvinas Inc | G. Houston John | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 124,450 | 1,041,877 (2%) | 0% | 0 | Common Stock | |
| Life Time Grp Holdings Inc | Akradi Bahram | Director, FOUNDER & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 120,192 | 984,761 | - | 0 | Common Stock | |
| NVIDIA | Jones C. Harvey | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Feb 2024 | 119,724 | 18,860 (0%) | 0% | 0 | Common Stock | |
| NVIDIA | Harvey Jones C. | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Feb 2024 | 119,724 | 796,120 (0%) | 0% | 0 | Common Stock | |
| Cleanspark Inc | Schultz S. Matthew | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.43 per share. | 23 Feb 2024 | 118,800 | 3,139,968 (64%) | 2% | 16.4 | 1,951,884 | Common Stock |
| Cleanspark Inc | S. Schultz Matthew | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.35 per share. | 23 Feb 2024 | 118,800 | 3,021,168 (62%) | 2% | 20.4 | 2,417,580 | Common Stock |
| Cleanspark Inc | K. Bradford Zachary | Director, CEO and President | 23 Feb 2024 | 118,050 | 3,757,806 (77%) | 2% | 16.4 | 1,939,562 | Common Stock | |
| Cleanspark Inc | Bradford K. Zachary | Director, CEO and President | 23 Feb 2024 | 118,050 | 3,639,756 (74%) | 2% | 20.4 | 2,402,318 | Common Stock | |
| TELA Bio Inc | Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 113,200 | 113,200 | - | - | Stock Option (Right to Buy) | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Sale of securities on an exchange or to another person at price $ 2.23 per share. | 23 Feb 2024 | 112,108 | 116,474 | - | 2.2 | 250,247 | Class A Common Stock |
| Alkermes PLC | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 111,186 | 111,186 | - | - | Employee Stock Option (Right to Buy) | |
| Alkermes PLC | Joseph Gaffin David | EVP, CLO, Alkermes, Inc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 111,186 | 111,186 | - | - | Employee Stock Option (Right to Buy) | |
| Vertex Inc (Class A) | DeStefano David | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 109,233 | 556,861 | - | 0 | Class A Common Stock | |
| Vertex Inc (Class A) | DeStefano David | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 109,233 | 218,465 | - | - | Restricted Stock Units | |
| Avantor Inc | Michael Stubblefield | Director, President & CEO | 23 Feb 2024 | 107,802 | 1,219,553 (0%) | 0% | 0 | Common Stock | ||
| Pfizer | Albert Bourla | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.37 per share. | 23 Feb 2024 | 103,178 | 327,739 (0%) | 0% | 27.4 | 2,823,982 | Common Stock |
| Exact Sciences Corp | T. Kevin Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.96 per share. | 23 Feb 2024 | 102,837 | 1,344,266 (0%) | 0% | 14.0 | 1,435,605 | Common Stock |
| Exact Sciences Corp | T. Kevin Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 102,837 | 0 | - | - | Stock Option (right to buy) | |
| Vertex Inc (Class A) | DeStefano David | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 101,395 | 304,186 | - | - | Restricted Stock Units | |
| Vertex Inc (Class A) | David DeStefano | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 101,395 | 493,585 | - | 0 | Class A Common Stock | |
| Oceaneering Intl Inc | Roderick A. Larson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 100,962 | 483,078 (0%) | 0% | 0 | Common Stock | |
| IAC Inc - Ordinary Shares - New | M. Levin Joseph | Director, CEO | 23 Feb 2024 | 100,000 | 3,387,614 | - | 13.5 | 1,348,000 | Common Stock, par value $0.0001 | |
| IAC Inc - Ordinary Shares - New | Levin M. Joseph | Director, CEO | 23 Feb 2024 | 100,000 | 0 | - | - | Options to Purchase Common Stock, par value $0.0001 | ||
| Medpace Holdings Inc | August Troendle J. | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 400.32 per share. | 23 Feb 2024 | 100,000 | 5,289,947 (14%) | 0% | 400.3 | 40,032,000 | Common Stock |
| Sarcos Tech and Robotics Corp | D. Andrew Hamer | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 100,000 | 250,565 | - | 0 | Common Stock | |
| Sarcos Tech and Robotics Corp | Matthew Vogt | CHIEF REVENUE OFFICER | 23 Feb 2024 | 100,000 | 114,105 | - | 0 | Common Stock | ||
| Sarcos Tech and Robotics Corp | Sonne Stephen | CHIEF LEGAL OFFICER | 23 Feb 2024 | 100,000 | 142,820 | - | 0 | Common Stock | ||
| Option Care Health Inc - Registered Shares | John Charles Rademacher | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.24 per share. | 23 Feb 2024 | 99,252 | 596,399 (0%) | 0% | 32.2 | 3,199,884 | Common Stock |
| Pfizer | Lankler Douglas M. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 95,755 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Douglas Lankler M. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2024 | 95,755 | 230,920 (0%) | 0% | 27.3 | 2,617,942 | Common Stock |
| Fluor Corp | Constable David E. | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 94,545 | 909,884 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | I. Helen Torley | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 93,002 | 93,002 | - | - | Option to Purchase Common Stock | |
| SunCoke Energy Inc | Rippey Michael G. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 92,986 | 0 | - | - | RSUs (02.25.2021) | |
| SunCoke Energy Inc | Michael Rippey G. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 92,986 | 834,106 (0%) | 0% | - | Common Stock | |
| TrueBlue Inc | Taryn R. Owen | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 90,978 | 247,212 (0%) | 0% | 0 | Common Stock | |
| Alkermes PLC | M. Iain Brown | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 90,971 | 90,971 | - | - | Employee Stock Option (Right to Buy) | |
| Halozyme Therapeutics Inc | Helen Torley I. | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 89,744 | 89,744 | - | - | Restricted Stock Units | |
| Artivion Inc | Mackin James Patrick | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 89,001 | 628,037 (1%) | 0% | 0 | Common Stock | |
| Fluor Corp | Constable David E. | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 88,431 | 88,431 | - | - | Employee Stock Option (Right to Buy) | |
| Cushman & Wakefield PLC | Michelle MacKay | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 87,635 | 234,485 (0%) | 0% | 0 | Ordinary Shares | |
| Alkermes PLC | Christian Todd Nichols | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 87,602 | 87,602 | - | - | Employee Stock Option (Right to Buy) | |
| H&R Block Inc | Jeffrey Jones J. | Director, President & CEO | 23 Feb 2024 | 85,921 | 755,359 (0%) | 0% | 49.2 | 4,228,593 | Common Stock | |
| Tenaya Therapeutics Inc | Ali Faraz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 85,000 | 198,079 | - | 0 | Common Stock | |
| Fiserv | Frank J. Bisignano | Director, Chairman, President and CEO | 23 Feb 2024 | 84,236 | 3,131,812 (0%) | 0% | 150.8 | 12,699,419 | Common Stock | |
| Exelixis Inc | J. Senner Christopher | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 82,121 | 751,990 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | 23 Feb 2024 | 82,121 | 322,121 (0%) | 0% | 0 | Common Stock | ||
| RXO Inc | Wilkerson M. Drew | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 80,867 | 494,337 | - | - | Restricted Stock Unit | |
| RXO Inc | M. Drew Wilkerson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 80,867 | 149,627 | - | 0 | Common Stock | |
| Citigroup | Fraser Jane Nind | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 79,190 | 79,190 | - | - | Performance Share Unit | |
| Cleanspark Inc | Zimmerman Andrew | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.35 per share. | 23 Feb 2024 | 78,700 | 580,635 (11%) | 1% | 20.4 | 1,601,545 | Common Stock |
| Cleanspark Inc | Andrew Zimmerman | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.43 per share. | 23 Feb 2024 | 78,700 | 659,335 (13%) | 1% | 16.4 | 1,293,041 | Common Stock |
| Schneider National Inc (Class B) | Mark B. Rourke | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Feb 2024 | 78,481 | 262,690 (0%) | 0% | 0 | Class B Common Stock | |
| Schneider National Inc (Class B) | B. Mark Rourke | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Feb 2024 | 78,481 | 805,251 (0%) | 0% | 0 | Class B Common Stock | |
| Neogenomics Inc | Sherman Jeffrey S. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 77,913 | 77,913 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 77,500 | 381,134 (3%) | 0% | 0 | Common Stock | |
| Pfizer | Lankler Douglas M. | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.37 per share. | 23 Feb 2024 | 77,384 | 146,918 (0%) | 0% | 27.4 | 2,118,000 | Common Stock |
| Tenaya Therapeutics Inc | Timothy Hoey | Chief Scientific Officer | 23 Feb 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to buy) | ||
| Cushman & Wakefield PLC | White Brett | Director, Executive Chairman | 23 Feb 2024 | 74,239 | 74,239 | - | - | Restricted Stock Units | ||
| Cushman & Wakefield PLC | White Brett | Director, Executive Chairman | 23 Feb 2024 | 74,239 | 1,511,578 (0%) | 0% | 0 | Ordinary Shares | ||
| Arch Capital | Papadopoulo Nicolas | OFFICER OF SUBSIDIARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 73,702 | 704,089 (0%) | 0% | 0 | Common Shares, $.0011 par value per share | |
| SunCoke Energy Inc | Rippey Michael G. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 72,752 | 854,925 (1%) | 0% | - | Common Stock | |
| SunCoke Energy Inc | Michael G. Rippey | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 72,752 | 73,751 | - | - | RSUs (02.24.2022) | |
| Stagwell Inc (Class A) | Mark Penn | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.90 per share. | 23 Feb 2024 | 70,024 | 2,470,469 | - | 6.9 | 483,166 | Class A Common Stock |
| Schneider National Inc (Class B) | Rourke Mark B. | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.45 per share. | 23 Feb 2024 | 69,626 | 341,171 (0%) | 0% | 25.5 | 1,771,982 | Class B Common Stock |
| LPL Fin Holdings Inc | Arnold Dan | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 68,800 | 201,968 (0%) | 0% | 0 | Common Stock | |
| OneSpaWorld Holdings Ltd | Andrew R. Heyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.75 per share. | 23 Feb 2024 | 66,667 | 634,937 (1%) | 0% | 5.7 | 383,335 | Common Shares |
| OneSpaWorld Holdings Ltd | R. Andrew Heyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 66,667 | 0 | - | - | Warrant (right to buy) | |
| Cushman & Wakefield PLC | Brett White | Director, Executive Chairman | 23 Feb 2024 | 66,116 | 1,437,339 (0%) | 0% | 9.8 | 649,259 | Ordinary Shares | |
| IAC Inc - Ordinary Shares - New | M. Levin Joseph | Director, CEO | 23 Feb 2024 | 65,928 | 3,321,686 | - | 56.7 | 3,737,458 | Common Stock, par value $0.0001 | |
| L3Harris Tech | Christopher E. Kubasik | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 65,841 | 65,841 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Xenia Hotels & Resorts Inc | Marcel Verbaas | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 64,960 | 1,032,876 | - | - | LTIP Units | |
| Airbnb | Lin Alfred | Director | Other type of transaction at price $ 0.00 per share. | 23 Feb 2024 | 63,938 | 442,320 | - | 0 | Class A Common Stock | |
| Pfizer | Susman Sally | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 63,837 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Susman Sally | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2024 | 63,837 | 218,148 (0%) | 0% | 27.3 | 1,745,304 | Common Stock |
| Exelixis Inc | Patrick J. Haley | EVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 63,350 | 431,886 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dana Aftab T. | CSO/EVP Disc & Trans Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 63,350 | 542,381 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Jeffrey Hessekiel J. | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 63,350 | 655,052 (0%) | 0% | 0 | Common Stock | |
| SunCoke Energy Inc | Michael Rippey G. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 63,124 | 126,247 | - | - | RSUs (02.23.2023) | |
| SunCoke Energy Inc | Michael G. Rippey | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 63,124 | 776,375 (0%) | 0% | - | Common Stock | |
| Avantor Inc | Brent R. Jones | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 62,753 | 62,753 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc | Lee Stone Randy | EVP, Proprietary Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 62,753 | 62,753 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 62,753 | 62,753 | - | - | Stock Options (Right to Buy) | |
| Exact Sciences Corp | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.53 per share. | 23 Feb 2024 | 61,560 | 1,282,706 (0%) | 0% | 57.5 | 3,541,547 | Common Stock |
| ARKO Corp (Class A) | Arie Kotler | Director, Chairman, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.00 per share. | 23 Feb 2024 | 61,342 | 11,487,330 | - | 8 | 490,736 | Common Stock, par value $0.0001 per share |
| Robinhood Markets Inc (Class A) | Steven M. Quirk | Chief Brokerage Officer | Sale of securities on an exchange or to another person at price $ 14.43 per share. | 23 Feb 2024 | 60,895 | 350,769 | - | 14.4 | 878,544 | Class A Common Stock |
| Restaurant Brands Intl Inc | B. Curtis Thomas | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 59,697 | 59,697 | - | - | Performance Share Units | |
| Artivion Inc | James Mackin Patrick | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 58,648 | 708,945 (1%) | 0% | 0 | Common Stock | |
| Artivion Inc | James Patrick Mackin | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 58,648 | 709,221 (1%) | 0% | 0 | Common Stock | |
| Arvinas Inc | Ian Taylor | Chief Scientific Officer | 23 Feb 2024 | 58,100 | 58,100 | - | - | Stock Option (right to buy) | ||
| Arvinas Inc | Peck Ronald | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 58,100 | 58,100 | - | - | Stock Option (right to buy) | |
| BRC Inc (Class A) | Christopher John Clark | CTO & COO | 23 Feb 2024 | 57,545 | 187,881 | - | 0 | Class A Common Stock | ||
| Tenet Healthcare Corp | Sutaria Saumya | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.80 per share. | 23 Feb 2024 | 57,452 | 478,577 (0%) | 0% | 92.8 | 5,331,546 | Common Stock |
| Medpace Holdings Inc | J. Troendle August | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 402.38 per share. | 23 Feb 2024 | 56,928 | 5,233,019 (14%) | 0% | 402.4 | 22,906,689 | Common Stock |
| Transmedics Grp Inc | Hassanein Waleed | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 56,645 | 56,645 | - | - | Stock Option (Right to Buy) | |
| St. Joe Co. | R. Berkowitz Bruce | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 54.05 per share. | 23 Feb 2024 | 56,500 | 19,330,524 (32%) | 0% | 54.1 | 3,053,825 | Common Stock |
| Vertex Inc (Class A) | David DeStefano | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.71 per share. | 23 Feb 2024 | 55,873 | 500,988 | - | 24.7 | 1,380,622 | Class A Common Stock |
| Bank of New York Mellon | Mccarthy J. Kevin | SEVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 53,960 | 167,951 (0%) | 0% | 0 | Common Stock | |
| Bank of New York Mellon | Senthilkumar Santhanakrishnan | Senior Exec VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 53,960 | 187,912 (0%) | 0% | 0 | Common Stock | |
| Terex Corp | John Garrison L. | Former DIR, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 53,418 | 464,398 (0%) | 0% | 0 | Common Stock, par value $.01 | |
| StepStone Grp Inc (Class A) | Thomas Keck | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 35.47 per share. | 23 Feb 2024 | 53,403 | 204,444 | - | 35.5 | 1,894,204 | Class A Common Stock |
| Portland General Electric Co | Pope M. Maria | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 41.44 per share. | 23 Feb 2024 | 53,315 | 226,910 (0%) | 0% | 41.4 | 2,209,374 | Common Stock |
| Restaurant Brands Intl Inc | Axel Schwan MR | Pres., Tim Hortons Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 53,064 | 53,064 | - | - | Performance Share Units | |
| Restaurant Brands Intl Inc | Axel MR Schwan | Pres., Tim Hortons Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 53,064 | 53,064 | - | - | Performance Share Units | |
| Criteo S.A (ADR) | Sarah Glickman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 52,966 | 302,672 (0%) | 0% | 0 | Ordinary Shares | |
| Bank of New York Mellon | Keating Catherine | Sr. Exec. Vice President | 23 Feb 2024 | 52,881 | 161,664 (0%) | 0% | 0 | Common Stock | ||
| Frontier Grp Holdings Inc | L. Biffle Barry | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 52,491 | 938,099 | - | - | Common Stock | |
| Frontier Grp Holdings Inc | Biffle Barry L. | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 52,491 | 0 | - | - | Restricted Stock Units | |
| Westwood Holdings Grp Inc | Brian Casey O. | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 52,083 | 489,061 (5%) | 0% | 0 | common stock | |
| SunCoke Energy Inc | Michael G. Rippey | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.84 per share. | 23 Feb 2024 | 51,933 | 782,173 (0%) | 0% | 10.8 | 562,954 | Common Stock |
| Pfizer | Susman Sally | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.37 per share. | 23 Feb 2024 | 51,589 | 161,611 (0%) | 0% | 27.4 | 1,411,991 | Common Stock |
| Rithm Cap Corp | Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 51,401 | 51,401 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Hallador Energy Co | Lubar J. David | Director, Ten Percent Owner | Other type of transaction at price $ 6.25 per share. | 23 Feb 2024 | 51,168 | 1,204,040 (3%) | 0% | 6.3 | 320,005 | Common Stock |
| Avantor Inc | James Bramwell | EVP Sales, Customer Excellence | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 50,204 | 50,204 | - | - | Stock Options (Right to Buy) | |
| AG Mortgage Investment Trust Inc | Thomas Durkin J. | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 6.12 per share. | 23 Feb 2024 | 50,000 | 372,832 (1%) | 0% | 6.1 | 306,155 | Common Stock |
| First Hawaiian INC | Harrison S. Robert | Director, CHAIRMAN, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 49,644 | 390,338 (0%) | 0% | 0 | Common Stock | |
| Alarm.com Holdings Inc | Stephen Trundle | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.79 per share. | 23 Feb 2024 | 49,400 | 1,289,943 (2%) | 0% | 73.8 | 3,645,226 | Common Stock |
| Wyndham Hotels & Resorts Inc | A. Geoffrey Ballotti | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 49,072 | 324,236 (0%) | 0% | 0 | Common Stock | |
| Cushman & Wakefield PLC | Michelle MacKay | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.82 per share. | 23 Feb 2024 | 48,463 | 186,022 (0%) | 0% | 9.8 | 475,907 | Ordinary Shares |
| Westwood Holdings Grp Inc | Brian O. Casey | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 48,230 | 480,214 (5%) | 0% | - | common stock | |
| Agios Pharma Inc | David P. Schenkein | Director | 23 Feb 2024 | 47,731 | 89,740 | - | - | Stock option (right to buy) | ||
| Agios Pharma Inc | P. Schenkein David | Director | 23 Feb 2024 | 47,731 | 122,854 (0%) | 0% | 33.1 | 1,577,510 | Common stock | |
| Agios Pharma Inc | P. Schenkein David | Director | 23 Feb 2024 | 47,731 | 170,585 (0%) | 0% | 31.6 | 1,510,209 | Common stock | |
| Exelixis Inc | Patrick J. Haley | EVP, Commercial | Sale of securities on an exchange or to another person at price $ 21.45 per share. | 23 Feb 2024 | 47,020 | 384,866 (0%) | 0% | 21.5 | 1,008,579 | Common Stock |
| Neogenomics Inc | S. Sherman Jeffrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 46,606 | 46,606 | - | - | Performance Stock Unit | |
| Neogenomics Inc | S. Jeffrey Sherman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 46,606 | 46,606 | - | - | Restricted Stock Unit | |
| Cushman & Wakefield PLC | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 46,208 | 267,308 (0%) | 0% | 0 | Ordinary Shares | |
| Vertex Inc (Class A) | David DeStefano | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.71 per share. | 23 Feb 2024 | 45,957 | 447,628 | - | 24.7 | 1,135,597 | Class A Common Stock |
| Taylor Morrison Home Corp | D. Palmer Sheryl | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 45,680 | 45,680 | - | - | Restricted Stock Units | |
| Outset Medical Inc | Trigg Leslie L. | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.72 per share. | 23 Feb 2024 | 45,538 | 919,240 | - | 3.7 | 169,401 | Common Stock |
| ACV Auctions Inc (Class A) | Chamoun George G. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 16.52 per share. | 23 Feb 2024 | 45,528 | 621,164 | - | 16.5 | 752,123 | Class A Common Stock |
| NCR Voyix Corp | David Wilkinson | Director, Chief Executive Officer | 23 Feb 2024 | 45,445 | 258,356 (0%) | 0% | 0 | Common Stock | ||
| NCR Voyix Corp | David Wilkinson | Director, Chief Executive Officer | 23 Feb 2024 | 45,445 | 0 | - | - | Restricted Stock | ||
| NCR Atleos Corp | Oliver C. Timothy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 45,444 | 254,577 | - | 0 | Common Stock | |
| NCR Atleos Corp | Oliver C. Timothy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 45,444 | 0 | - | - | Restricted Stock Units | |
| Skyward Specialty Insurance Grp Inc | W. Mark Haushill | EVP & CFO | Sale of securities on an exchange or to another person at price $ 35.80 per share. | 23 Feb 2024 | 45,000 | 191,688 | - | 35.8 | 1,611,000 | Common Stock |
| Tactile Systems Tech Inc | Daniel L. Reuvers | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 44,930 | 237,251 (1%) | 0% | 0 | Common Stock | |
| Equifax | Gamble John W. | EVP, CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 265.18 per share. | 23 Feb 2024 | 44,834 | 65,810 (0%) | 0% | 265.2 | 11,889,080 | Common Stock |
| Arch Capital | Rajeh Maamoun | CHAIRMAN & CEO ARCH RE GROUP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 44,528 | 380,323 (0%) | 0% | 0 | Common Shares, $.0011 par value per share | |
| Arch Capital | David Gansberg | CEO, GLOBAL MORTGAGE GROUP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 44,528 | 252,896 (0%) | 0% | 0 | Common Shares, $.0011 par value per share | |
| TELA Bio Inc | Cuca Roberto | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 42,700 | 42,700 | - | - | Stock Option (Right to Buy) | |
| Avantor Inc | Claudius Sokenu | EVP, Chief Legal & Compliance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 42,674 | 42,674 | - | - | Stock Options (Right to Buy) | |
| Neogenomics Inc | Warren Stone | President, Clinical Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 42,344 | 42,344 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc | Harris Melody | President, Enterprise Ops | 23 Feb 2024 | 42,344 | 42,344 | - | - | Stock Option (Right to Buy) | ||
| Neogenomics Inc | Vishal Sikri | President Advanced Diagnostics | 23 Feb 2024 | 42,344 | 42,344 | - | - | Stock Option (Right to Buy) | ||
| Neogenomics Inc | C. Alicia Olivo | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 42,344 | 42,344 | - | - | Stock Option (Right to Buy) | |
| State Street | P. O'Hanley Ronald | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 41,988 | 229,583 (0%) | 0% | 0 | Common Stock | |
| Westwood Holdings Grp Inc | Helfert Adrian | CIO, Multi-Asset Inv. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 41,667 | 168,115 (1%) | 0% | 0 | common stock | |
| Taylor Morrison Home Corp | D. Palmer Sheryl | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 41,592 | 41,592 | - | - | Employee Stock Option (Right to Buy) | |
| Arch Capital | Morin Francois | EVP AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 41,458 | 234,984 (0%) | 0% | 0 | Common Shares, $.0011 par value per share | |
| Cushman & Wakefield PLC | Robinson Nathaniel | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 41,428 | 87,153 (0%) | 0% | 0 | Ordinary Shares | |
| SunCoke Energy Inc | Michael G. Rippey | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.84 per share. | 23 Feb 2024 | 41,191 | 813,734 (0%) | 0% | 10.8 | 446,510 | Common Stock |
| LPL Fin Holdings Inc | Arnold Dan | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 263.36 per share. | 23 Feb 2024 | 41,015 | 160,953 (0%) | 0% | 263.4 | 10,801,710 | Common Stock |
| Bank of New York Mellon | Roman Regelman | Sr. Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 40,469 | 170,486 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Patrick James Mackin | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 40,404 | 668,441 (1%) | 0% | 0 | Common Stock | |
| Artivion Inc | James Patrick Mackin | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 40,404 | 668,441 (1%) | 0% | 0 | Common Stock | |
| State Street | P. Ronald O'Hanley | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 39,665 | 39,665 | - | - | 2024 Cash Settled Restricted Stock Units | |
| Arvinas Inc | Taylor Ian | Chief Scientific Officer | 23 Feb 2024 | 39,250 | 149,223 (0%) | 0% | 0 | Common Stock | ||
| Arvinas Inc | Peck Ronald | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 39,250 | 69,215 (0%) | 0% | 0 | Common Stock | |
| Cushman & Wakefield PLC | Brett White | Director, Executive Chairman | 23 Feb 2024 | 39,087 | 1,472,491 (0%) | 0% | 9.8 | 383,834 | Ordinary Shares | |
| Bank of New York Mellon | Hanneke Smits | Sr. Exec. Vice President | 23 Feb 2024 | 38,542 | 207,045 (0%) | 0% | 0 | Common Stock | ||
| Vitesse Energy Inc | Robert W. Gerrity | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 38,029 | 1,454,241 | - | 0 | Common Stock | |
| Cushman & Wakefield PLC | Michelle MacKay | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 37,992 | 75,984 | - | - | Restricted Stock Units | |
| Cushman & Wakefield PLC | Michelle MacKay | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 37,992 | 142,749 (0%) | 0% | 0 | Ordinary Shares | |
| Stagwell Inc (Class A) | P. Lanuto Frank | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.90 per share. | 23 Feb 2024 | 37,675 | 668,070 | - | 6.9 | 259,958 | Class A Common Stock |
| Artivion Inc | Lance Berry A. | Executive VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 37,000 | 79,064 (0%) | 0% | 0 | Common Stock | |
| Transmedics Grp Inc | Hassanein Waleed | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 36,755 | 543,446 (2%) | 0% | 0 | Common Stock | |
| Citigroup | Ernesto Torres Cantu | Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 36,271 | 36,271 | - | - | Performance Share Unit | |
| BlackRock | Lord Rachel | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 36,059 | 18,036 | - | - | Employee Stock Option (Right to Buy) | |
| BlackRock | Rachel Lord | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 513.50 per share. | 23 Feb 2024 | 36,059 | 53,063 (0%) | 0% | 513.5 | 18,516,297 | Common Stock |
| Prudential Financial | Y. Kenneth Tanji | EVP and CFO | Sale of securities on an exchange or to another person at price $ 108.69 per share. | 23 Feb 2024 | 36,052 | 25,227 (0%) | 0% | 108.7 | 3,918,492 | Common Stock |
| Par Pacific Holdings Inc | William Monteleone | Director, President | Grant, award, or other acquisition of securities at price $ 39.09 per share. | 23 Feb 2024 | 35,988 | 349,389 (0%) | 0% | 39.1 | 1,406,771 | Common stock |
| RXO Inc | M. Wilkerson Drew | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.46 per share. | 23 Feb 2024 | 35,905 | 113,722 | - | 21.5 | 770,521 | Common Stock |
| Citigroup | Peter Babej | Interim Head of Banking | 23 Feb 2024 | 35,825 | 35,825 | - | - | Performance Share Unit | ||
| Par Pacific Holdings Inc | William Monteleone | Director, President | Grant, award, or other acquisition of securities at price $ 39.09 per share. | 23 Feb 2024 | 35,636 | 349,037 (0%) | 0% | 39.1 | 1,393,011 | Common stock |
| Criteo S.A (ADR) | Damon Ryan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 35,311 | 152,504 (0%) | 0% | 0 | Ordinary Shares | |
| SunCoke Energy Inc | G. Michael Rippey | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.84 per share. | 23 Feb 2024 | 35,255 | 741,120 (0%) | 0% | 10.8 | 382,164 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Haushill W. Mark | EVP & CFO | Sale of securities on an exchange or to another person at price $ 35.96 per share. | 23 Feb 2024 | 35,000 | 261,688 | - | 36.0 | 1,258,600 | Common Stock |
| Tenaya Therapeutics Inc | Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 35,000 | 108,534 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | D Patterson Leone | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 35,000 | 95,755 | - | 0 | Common Stock | |
| Cushman & Wakefield PLC | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 34,878 | 210,758 (0%) | 0% | 0 | Ordinary Shares | |
| Cushman & Wakefield PLC | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 34,878 | 69,756 | - | - | Restricted Stock Units | |
| Addus HomeCare Corp | Allison R. Dirk | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 34,568 | 87,418 (0%) | 0% | 0 | Common Stock | |
| TrueBlue Inc | Schweihs R. Carl | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 33,941 | 100,691 (0%) | 0% | 0 | Common Stock | |
| Hilltop Holdings Inc | Steve B. Thompson | PrimeLending President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 33,855 | 118,042 (0%) | 0% | 0 | Common Stock | |
| Piedmont Office Realty Trust Inc (Class A) | Brent Christopher Smith | Director, President & Chief Exec. Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 33,791 | 339,036 (0%) | 0% | - | Common Stock | |
| Piedmont Office Realty Trust Inc (Class A) | Christopher Smith Brent | Director, President & Chief Exec. Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 33,791 | 399,940 | - | - | Restricted Stock Units | |
| Cushman & Wakefield PLC | MacKay Michelle | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 33,682 | 165,477 (0%) | 0% | 0 | Ordinary Shares | |
| Cushman & Wakefield PLC | Michelle MacKay | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 33,682 | 0 | - | - | Restricted Stock Units | |
| Oceaneering Intl Inc | R. Curtis Alan | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 33,620 | 194,897 (0%) | 0% | 0 | Common Stock | |
| Weyerhaeuser | Nicole Piasecki W. | Director | Sale of securities on an exchange or to another person at price $ 33.64 per share. | 23 Feb 2024 | 33,426 | 5,807 (0%) | 0% | 33.6 | 1,124,327 | Common |
| OneSpaWorld Holdings Ltd | Heyer Andrew R. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 33,333 | 0 | - | - | Warrant (right to buy) | |
| OneSpaWorld Holdings Ltd | R. Heyer Andrew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.75 per share. | 23 Feb 2024 | 33,333 | 495,461 (0%) | 0% | 5.8 | 191,665 | Common Shares |
| Alkermes PLC | C. Blair Jackson | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 33,289 | 33,289 | - | - | Restricted Stock Unit Award | |
| WEX Inc | Melissa D. Smith | Director, Chair, CEO, and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 33,184 | 33,184 | - | - | Restricted Stock Units | |
| Westwood Holdings Grp Inc | Gomez Fabian | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 32,907 | 88,323 (0%) | 0% | 0 | common stock | |
| Waste Management | James Fish C. | Pres, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 110.81 per share. | 23 Feb 2024 | 32,850 | 258,104 (0%) | 0% | 110.8 | 3,640,109 | Common Stock |
| Waste Management | Fish James C. | Pres, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 32,850 | 0 | - | - | Stock Option (Right to Buy) | |
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 23 Feb 2024 | 32,794 | 754,038 | - | - | Class B Common Stock | ||
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 23 Feb 2024 | 32,794 | 670,794 (0%) | 0% | 0 | Class A Common Stock | ||
| Stagwell Inc (Class A) | Jay Leveton | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.90 per share. | 23 Feb 2024 | 32,295 | 459,530 | - | 6.9 | 222,836 | Class A Common Stock |
| Xenia Hotels & Resorts Inc | Bloom Barry A.N. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 32,010 | 439,804 | - | - | LTIP Units | |
| L3Harris Tech | E. Christopher Kubasik | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 31,657 | 119,057 (0%) | 0% | 0 | Common Stock, Par Value $1.00 | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 23 Feb 2024 | 31,493 | 31,493 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 23 Feb 2024 | 31,493 | 295,570,096 | - | - | Class B Common Stock | ||
| Agree Realty Corp | N. Agree Joel | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 31,299 | 592,702 (1%) | 0% | 0 | Common Shares | |
| TrueBlue Inc | Ferencz Garrett R. | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 30,547 | 90,901 (0%) | 0% | 0 | Common Stock | |
| Portland General Electric Co | Maria M. Pope | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.44 per share. | 23 Feb 2024 | 30,523 | 196,387 (0%) | 0% | 41.4 | 1,264,873 | Common Stock |
| Vertex Inc (Class A) | R. John Schwab | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 30,305 | 68,726 | - | 0 | Class A Common Stock | |
| Vertex Inc (Class A) | John R. Schwab | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 30,305 | 90,915 | - | - | Restricted Stock Units | |
| L3Harris Tech | Kubasik Christopher E. | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 30,235 | 0 | - | - | Performance Stock Units | |
| Avantor Inc | Sahin Kitty | EVP, Strategy&Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 30,122 | 30,122 | - | - | Stock Options (Right to Buy) | |
| Bank of New York Mellon | A. Vince Robin | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 30,015 | 265,216 (0%) | 0% | 0 | Common Stock | |
| Hilltop Holdings Inc | M. Winges Bradley | Hilltop Securities CEO | Sale of securities on an exchange or to another person at price $ 30.83 per share. | 23 Feb 2024 | 30,000 | 98,933 (0%) | 0% | 30.8 | 924,882 | Common Stock |
| Vaxcyte Inc | E. Pickering Grant | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 79.03 per share. | 23 Feb 2024 | 30,000 | 375,814 | - | 79.0 | 2,370,900 | Common Stock |
| Vaxcyte Inc | Pickering E. Grant | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 30,000 | 30,225 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.79 per share. | 23 Feb 2024 | 30,000 | 405,814 | - | 1.8 | 53,700 | Common Stock |
| Quad/Graphics Inc (Class A) | Buth Douglas | Director | Sale or transfer of securities back to the company at price $ 5.76 per share. | 23 Feb 2024 | 29,700 | 144,041 (0%) | 0% | 5.8 | 170,977 | Class A Common Stock |
| State Street | Hung Yie-Hsin | EVP; President and CEO of SSGA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 29,505 | 82,324 (0%) | 0% | 0 | Common Stock | |
| Pfizer | A. Rady Johnson | Executive Vice President | 23 Feb 2024 | 29,436 | 0 | - | - | Stock Appreciation Rights | ||
| Pfizer | A. Johnson Rady | Executive Vice President | 23 Feb 2024 | 29,436 | 123,073 (0%) | 0% | 27.3 | 804,780 | Common Stock | |
| Bank of Hawaii Corp | Ho Peter S. | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 29,412 | 29,412 | - | - | Restricted Stock Units | |
| Bank of New York Mellon | Catherine Keating | Sr. Exec. Vice President | 23 Feb 2024 | 29,245 | 132,419 (0%) | 0% | 55.6 | 1,627,192 | Common Stock | |
| TELA Bio Inc | Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 29,200 | 92,650 (0%) | 0% | 0 | Common Stock | |
| ACV Auctions Inc (Class A) | Mehta Vikas | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 16.52 per share. | 23 Feb 2024 | 29,197 | 333,327 | - | 16.5 | 482,334 | Class A Common Stock |
| ACV Auctions Inc (Class A) | William R. Zerella | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 16.52 per share. | 23 Feb 2024 | 29,197 | 334,776 | - | 16.5 | 482,334 | Class A Common Stock |
| ACV Auctions Inc (Class A) | Waterman Michael | Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 16.52 per share. | 23 Feb 2024 | 29,124 | 249,087 | - | 16.5 | 481,128 | Class A Common Stock |
| Halozyme Therapeutics Inc | Mark Snyder | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 29,064 | 29,064 | - | - | Option to Purchase Common Stock | |
| Mesa Air Grp Inc | Ellen N. Artist | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. | 23 Feb 2024 | 28,935 | 108,103 (0%) | 0% | 0.9 | 26,910 | Common Stock |
| Mesa Air Grp Inc | Harvey W. Schiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. | 23 Feb 2024 | 28,935 | 93,877 (0%) | 0% | 0.9 | 26,910 | Common Stock |
| Mesa Air Grp Inc | Mitchell I. Gordon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. | 23 Feb 2024 | 28,935 | 111,903 (0%) | 0% | 0.9 | 26,910 | Common stock |
| Mesa Air Grp Inc | Lockhart Dana J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 28,935 | 0 | - | - | Restricted Stock Award | |
| Mesa Air Grp Inc | Artist N. Ellen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 28,935 | 0 | - | - | Restricted Stock Award | |
| Mesa Air Grp Inc | Gordon I. Mitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 28,935 | 0 | - | - | Restricted Stock Award | |
| Mesa Air Grp Inc | Skiados Spyridon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 28,935 | 0 | - | - | Restricted Stock Award | |
| Mesa Air Grp Inc | Harvey W. Schiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 28,935 | 0 | - | - | Restricted Stock Award | |
| Mesa Air Grp Inc | Dana J. Lockhart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. | 23 Feb 2024 | 28,935 | 120,603 (0%) | 0% | 0.9 | 26,910 | Common stock |
| Mesa Air Grp Inc | Spyridon Skiados | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. | 23 Feb 2024 | 28,935 | 92,803 (0%) | 0% | 0.9 | 26,910 | Common Stock |
| Regal Rexnord Corp | Louis Pinkham V. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 28,560 | 28,560 | - | - | Stock Appreciation Rights | |
| Halozyme Therapeutics Inc | Snyder Mark | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 28,045 | 28,045 | - | - | Restricted Stock Units | |
| Halozyme Therapeutics Inc | Nicole LaBrosse | SVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 27,722 | 27,722 | - | - | Option to Purchase Common Stock | |
| Arch Capital | T. Louis Petrillo | OFFICER OF SUBSIDIARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 27,638 | 132,067 (0%) | 0% | 0 | Common Shares, $.0011 par value per share | |
| Avantor Inc | Hankamer Brittany | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 27,612 | 27,612 | - | - | Stock Options (Right to Buy) | |
| Bank of New York Mellon | Mccarthy J. Kevin | SEVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.64 per share. | 23 Feb 2024 | 27,548 | 140,403 (0%) | 0% | 55.6 | 1,532,771 | Common Stock |
| Bank of New York Mellon | Santhanakrishnan Senthilkumar | Senior Exec VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.64 per share. | 23 Feb 2024 | 27,548 | 160,364 (0%) | 0% | 55.6 | 1,532,771 | Common Stock |
| Alkermes PLC | Joseph Gaffin David | EVP, CLO, Alkermes, Inc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 27,464 | 27,464 | - | - | Restricted Stock Unit Award | |
| Alkermes PLC | Craig Hopkinson C. | EVP R&D, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 27,464 | 27,464 | - | - | Restricted Stock Unit Award | |
| Cushman & Wakefield PLC | Neil O. Johnston | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 27,404 | 78,195 (0%) | 0% | 0 | Ordinary Shares | |
| Cushman & Wakefield PLC | Neil O. Johnston | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 27,404 | 54,809 | - | - | Restricted Stock Units | |
| Citigroup | Skyler Edward | Hd of Ent Svc & Public Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 27,145 | 27,145 | - | - | Performance Share Unit | |
| Halozyme Therapeutics Inc | Nicole LaBrosse | SVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 26,751 | 26,751 | - | - | Restricted Stock Units | |
| Itron Inc | Deitrich L. Thomas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 26,691 | 208,524 (0%) | 0% | 0 | Common Stock | |
| OneSpaWorld Holdings Ltd | Andrew Heyer R. | Director | Sale or transfer of securities back to the company at price $ 14.39 per share. | 23 Feb 2024 | 26,632 | 608,305 (0%) | 0% | 14.4 | 383,234 | Common Shares |
| Hilltop Holdings Inc | William Furr B. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 26,523 | 184,348 (0%) | 0% | 0 | Common Stock | |
| McGrath Rentcorp | Joseph F. Hanna | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 26,420 | 26,420 | - | - | Restricted Stock Unit | |
| Cleanspark Inc | Andrew Zimmerman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.93 per share. | 23 Feb 2024 | 26,244 | 554,391 (11%) | 0% | 20.9 | 549,287 | Common Stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Friedman Douglas | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.59 per share. | 23 Feb 2024 | 26,232 | 62,390 (0%) | 0% | 20.6 | 540,117 | Class A common stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Friedman Douglas | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 104.85 per share. | 23 Feb 2024 | 26,232 | 36,158 (0%) | 0% | 104.8 | 2,750,307 | Class A common stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Douglas Friedman | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 26,232 | 0 | - | - | Stock Option (Right to Buy) | |
| Peabody Energy Corp - Ordinary Shares New | Yeates R. Darren | EVP & COO | Sale of securities on an exchange or to another person at price $ 24.71 per share. | 23 Feb 2024 | 25,793 | 80,367 (0%) | 0% | 24.7 | 637,345 | Common Stock |
| Avantor Inc | Lee Stone Randy | EVP, Proprietary Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,667 | 74,867 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,667 | 42,453 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc | Brent R. Jones | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,667 | 25,667 (0%) | 0% | 0 | Common Stock | |
| BRC Inc (Class A) | McCormick Andrew | Gen. Counsel & Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,575 | 127,730 | - | 0 | Class A Common Stock | |
| Hackett Grp Inc | John R. Harris | Director | Sale or transfer of securities back to the company at price $ 24.34 per share. | 23 Feb 2024 | 25,473 | 3,077 (0%) | 0% | 24.3 | 620,013 | Common Stock |
| Xenia Hotels & Resorts Inc | Atish Shah | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,419 | 81,888 | - | - | LTIP Units | |
| Neogenomics Inc | Stone Warren | President, Clinical Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,330 | 25,330 | - | - | Performance Stock Unit | |
| Neogenomics Inc | Sikri Vishal | President Advanced Diagnostics | 23 Feb 2024 | 25,330 | 25,330 | - | - | Performance Stock Unit | ||
| Neogenomics Inc | Olivo C. Alicia | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,330 | 25,330 | - | - | Performance Stock Unit | |
| Neogenomics Inc | Melody Harris | President, Enterprise Ops | 23 Feb 2024 | 25,330 | 25,330 | - | - | Performance Stock Unit | ||
| Neogenomics Inc | Warren Stone | President, Clinical Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,329 | 25,329 | - | - | Restricted Stock Unit | |
| Neogenomics Inc | Harris Melody | President, Enterprise Ops | 23 Feb 2024 | 25,329 | 25,329 | - | - | Restricted Stock Unit | ||
| Neogenomics Inc | Olivo Alicia C. | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,329 | 25,329 | - | - | Restricted Stock Unit | |
| Neogenomics Inc | Sikri Vishal | President Advanced Diagnostics | 23 Feb 2024 | 25,329 | 25,329 | - | - | Restricted Stock Unit | ||
| Tenet Healthcare Corp | Saumya Sutaria | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 25,229 | 0 | - | - | 2021 Restricted Stock Units | |
| Tenet Healthcare Corp | Sutaria Saumya | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 25,229 | 548,816 (0%) | 0% | - | Common Stock | |
| ACV Auctions Inc (Class A) | Craig Anderson | CCDSO | Grant, award, or other acquisition of securities at price $ 16.52 per share. | 23 Feb 2024 | 25,216 | 216,742 | - | 16.5 | 416,568 | Class A Common Stock |
| Option Care Health Inc - Registered Shares | Michael Shapiro H. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.24 per share. | 23 Feb 2024 | 25,109 | 247,317 (0%) | 0% | 32.2 | 809,514 | Common Stock |
| Wyndham Hotels & Resorts Inc | Ballotti A. Geoffrey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.49 per share. | 23 Feb 2024 | 25,101 | 299,135 (0%) | 0% | 79.5 | 1,995,278 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Haushill Mark W. | EVP & CFO | Sale of securities on an exchange or to another person at price $ 35.58 per share. | 23 Feb 2024 | 25,000 | 236,688 | - | 35.6 | 889,500 | Common Stock |
| Community Health Systems Inc | Wayne T. Smith | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Feb 2024 | 24,826 | 5,083,075 (4%) | 0% | 0 | Common Stock | |
| Pfizer | Dolsten Mikael | President R&D | 23 Feb 2024 | 24,822 | 343,166 (0%) | 0% | 27.8 | 689,059 | Common Stock | |
| TELA Bio Inc | Talmo Paul | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 24,400 | 24,400 | - | - | Stock Option (Right to Buy) | |
| Agree Realty Corp | Joel N. Agree | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.51 per share. | 23 Feb 2024 | 24,293 | 588,994 (1%) | 0% | 57.5 | 1,397,090 | Common Shares |
| Equifax | W. Gamble John | EVP, CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 149.53 per share. | 23 Feb 2024 | 24,069 | 74,167 (0%) | 0% | 149.5 | 3,599,038 | Common Stock |
| Equifax | John Gamble W. | EVP, CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 24,069 | 0 | - | - | Stock Option/Right to Buy | |
| Shake Shack Inc (Class A) | Meyer Harris Daniel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 100.13 per share. | 23 Feb 2024 | 23,966 | 526,471 (1%) | 0% | 100.1 | 2,399,617 | Class A Common Stock, par value $0.001 per share |
| Pfizer | A. Johnson Rady | Executive Vice President | 23 Feb 2024 | 23,788 | 97,153 (0%) | 0% | 27.4 | 651,078 | Common Stock | |
| Waste Management | C. Fish James | Pres, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 207.76 per share. | 23 Feb 2024 | 23,552 | 234,552 (0%) | 0% | 207.8 | 4,893,164 | Common Stock |
| State Street | Aboaf W. Eric | Vice Chairman and CFO | 23 Feb 2024 | 23,471 | 161,063 (0%) | 0% | 0 | Common Stock | ||
| ACV Auctions Inc (Class A) | George Chamoun G. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.52 per share. | 23 Feb 2024 | 23,243 | 597,921 | - | 16.5 | 383,974 | Class A Common Stock |
| Pursuit Attractions and Hospitality Inc | David W. Barry | President - Pursuit | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 23,026 | 82,199 (0%) | 0% | 0 | Common Stock | |
| Frontier Grp Holdings Inc | Barry Biffle L. | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.26 per share. | 23 Feb 2024 | 22,964 | 915,135 | - | 7.3 | 166,719 | Common Stock |
| Cushman & Wakefield PLC | MacKay Michelle | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 22,643 | 144,317 (0%) | 0% | 0 | Ordinary Shares | |
| Cushman & Wakefield PLC | Michelle MacKay | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 22,643 | 22,643 | - | - | Restricted Stock Units | |
| Avantor Inc | Christophe Couturier | EVP, AMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 22,592 | 22,592 | - | - | Stock Options (Right to Buy) | |
| Alkermes PLC | Brown M. Iain | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 22,471 | 22,471 | - | - | Restricted Stock Unit Award | |
| P&G | A. Gary Coombe | CEO - Grooming | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 22,000 | 21,388 | - | - | Stock Option (Right to Buy) | |
| P&G | Coombe A. Gary | CEO - Grooming | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.29 per share. | 23 Feb 2024 | 22,000 | 58,845 (0%) | 0% | 80.3 | 1,766,380 | Common Stock |
| P&G | Gary A. Coombe | CEO - Grooming | Sale of securities on an exchange or to another person at price $ 161.32 per share. | 23 Feb 2024 | 22,000 | 36,845 (0%) | 0% | 161.3 | 3,549,104 | Common Stock |
| Riverview Bancorp Inc | L. Nies Gerald | Director | Purchase of securities on an exchange or from another person at price $ 4.84 per share. | 23 Feb 2024 | 22,000 | 190,692 (0%) | 0% | 4.8 | 106,590 | Common Stock |
| Fortive | James A. Lico | Director, President and CEO | 23 Feb 2024 | 21,966 | 409,404 (0%) | 0% | 86.1 | 1,891,492 | Common Stock | |
| TrueBlue Inc | Kristy Fitzsimmons Willis | EVP; President - PeopleReady | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 21,899 | 60,441 (0%) | 0% | 0 | Common Stock | |
| QuantumScape Corp (Class A) | McCarthy Michael O. | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 23 Feb 2024 | 21,840 | 731,629 | - | 6.2 | 134,663 | Class A Common Stock |
| Agenus Inc | Garo Armen H. | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.68 per share. | 23 Feb 2024 | 21,815 | 1,253,329 (0%) | 0% | 0.7 | 14,834 | Common Stock |
| Westwood Holdings Grp Inc | Bennett Leah | President-Westwood Wealth Mgmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 21,667 | 59,629 (0%) | 0% | 0 | common stock | |
| TrueBlue Inc | P Betori Richard | EVP; President - PeopleScout | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 21,661 | 70,893 (0%) | 0% | 0 | Common Stock | |
| Alkermes PLC | Todd Nichols Christian | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 21,638 | 21,638 | - | - | Restricted Stock Unit Award | |
| Mohawk Industries | Jeffrey S. Lorberbaum | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 21,564 | 63,904 (0%) | 0% | 0 | Common Stock | |
| QuantumScape Corp (Class A) | Singh Jagdeep | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.08 per share. | 23 Feb 2024 | 21,402 | 3,011,578 | - | 6.1 | 130,171 | Class A Common Stock |
| Regal Rexnord Corp | Louis Pinkham V. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 21,372 | 111,253 (0%) | 0% | 0 | Common Stock | |
| Western Union Co | Devin McGranahan | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.96 per share. | 23 Feb 2024 | 21,321 | 399,767 (0%) | 0% | 13.0 | 276,320 | Common Stock |
| Cushman & Wakefield PLC | MacKay Michelle | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.82 per share. | 23 Feb 2024 | 21,075 | 121,674 (0%) | 0% | 9.8 | 206,957 | Ordinary Shares |
| Tenet Healthcare Corp | Sutaria Saumya | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 21,065 | 21,066 | - | - | 2022 Restricted Stock Units | |
| Tenet Healthcare Corp | Sutaria Saumya | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 21,065 | 534,263 (0%) | 0% | - | Common Stock | |
| Outset Medical Inc | Ahmed Nabeel | Chief Financial Officer | 23 Feb 2024 | 20,922 | 333,516 | - | 0 | Common Stock | ||
| Alkermes PLC | Samuel Parisi J. | VP, Finance (Interim PAO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 20,890 | 20,890 | - | - | Employee Stock Option (Right to Buy) | |
| Cushman & Wakefield PLC | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 20,787 | 20,787 | - | - | Restricted Stock Units | |
| Cushman & Wakefield PLC | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 20,787 | 219,335 (0%) | 0% | 0 | Ordinary Shares | |
| Agree Realty Corp | N. Agree Joel | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 20,585 | 613,287 (1%) | 0% | 0 | Common Shares | |
| Avantor Inc | James Bramwell | EVP Sales, Customer Excellence | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 20,533 | 107,346 (0%) | 0% | 0 | Common Stock | |
| Stagwell Inc (Class A) | Greene Ryan | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.90 per share. | 23 Feb 2024 | 20,522 | 195,848 | - | 6.9 | 141,602 | Class A Common Stock |
| NCR Atleos Corp | Timothy C. Oliver | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.07 per share. | 23 Feb 2024 | 20,496 | 234,081 | - | 21.1 | 431,851 | Common Stock |
| LyondellBasell (Class A) | Todd Lane Kenneth | EVP, Olefins and Polyolefins | Sale of securities on an exchange or to another person at price $ 99.21 per share. | 23 Feb 2024 | 20,472 | 100,514 (0%) | 0% | 99.2 | 2,031,027 | Class A Ordinary Shares |
| LyondellBasell (Class A) | Lane Todd Kenneth | EVP, Olefins and Polyolefins | Exercise or conversion of derivative security received from the company (such as an option) at price $ 99.21 per share. | 23 Feb 2024 | 20,472 | 120,986 (0%) | 0% | 99.2 | 2,031,027 | Class A Ordinary Shares |
| LyondellBasell (Class A) | Lane Todd Kenneth | EVP, Olefins and Polyolefins | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 20,472 | 10,235 | - | - | Stock Options (Right to Buy) | |
| Agios Pharma Inc | David Schenkein P. | Director | 23 Feb 2024 | 20,411 | 143,265 (0%) | 0% | 31.6 | 645,804 | Common stock | |
| Agios Pharma Inc | P. David Schenkein | Director | 23 Feb 2024 | 20,411 | 122,854 (0%) | 0% | 33.2 | 677,441 | Common stock | |
| Agios Pharma Inc | P. David Schenkein | Director | 23 Feb 2024 | 20,411 | 69,329 | - | - | Stock option (right to buy) | ||
| NCR Voyix Corp | David Wilkinson | Director, Chief Executive Officer | 23 Feb 2024 | 20,378 | 237,978 (0%) | 0% | 15.0 | 306,485 | Common Stock | |
| RingCentral Inc (Class A) | Sonalee Parekh | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.83 per share. | 23 Feb 2024 | 20,255 | 348,155 (0%) | 0% | 30.8 | 624,482 | Class A Common Stock |
| Bank of Hawaii Corp | Ho S. Peter | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.20 per share. | 23 Feb 2024 | 20,172 | 189,425 (0%) | 0% | 61.2 | 1,234,526 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.